Details for New Drug Application (NDA): 218390
✉ Email this page to a colleague
The generic ingredient in INGREZZA SPRINKLE is valbenazine tosylate. One supplier is listed for this compound. Additional details are available on the valbenazine tosylate profile page.
Summary for 218390
Tradename: | INGREZZA SPRINKLE |
Applicant: | Neurocrine |
Ingredient: | valbenazine tosylate |
Patents: | 22 |
Pharmacology for NDA: 218390
Mechanism of Action | Vesicular Monoamine Transporter 2 Inhibitors |
Suppliers and Packaging for NDA: 218390
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
INGREZZA SPRINKLE | valbenazine tosylate | CAPSULE;ORAL | 218390 | NDA | Neurocrine Biosciences, Inc. | 70370-4040 | 70370-4040-1 | 30 CAPSULE in 1 BOTTLE (70370-4040-1) |
INGREZZA SPRINKLE | valbenazine tosylate | CAPSULE;ORAL | 218390 | NDA | Neurocrine Biosciences, Inc. | 70370-4060 | 70370-4060-1 | 30 CAPSULE in 1 BOTTLE (70370-4060-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 40MG BASE | ||||
Approval Date: | Apr 30, 2024 | TE: | RLD: | Yes | |||||
Regulatory Exclusivity Expiration: | Aug 18, 2026 | ||||||||
Regulatory Exclusivity Use: | TREATMENT OF ADULTS WITH CHOREA ASSOCIATED WITH HUNTINGTON’S DISEASE | ||||||||
Patent: | ⤷ Subscribe | Patent Expiration: | Oct 28, 2036 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | A METHOD OF TREATING HUNTINGTON'S CHOREA | ||||||||
Patent: | ⤷ Subscribe | Patent Expiration: | Oct 28, 2036 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | TREATMENT OF TARDIVE DYSKINESIA |
Complete Access Available with Subscription